1
|
Seiça Cardoso C, Prazeres F, Oliveiros B, Nunes C, Simões P, Aires C, Rita P, Penetra J, Lopes P, Alcobia S, Baptista S, Venâncio C, Gomes B. Feasibility and effectiveness of a two-tiered intervention involving training and a new consultation model for patients with palliative care needs in primary care: A before-after study. Palliat Med 2024; 38:842-852. [PMID: 38226491 PMCID: PMC11445974 DOI: 10.1177/02692163231219682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2024]
Abstract
BACKGROUND Evidence suggests that involving General Practitioners in the care of patients with palliative care needs may improve patient outcomes. AIM To evaluate whether a two-tiered intervention involving training in palliative care and a new consultation model in primary care for patients with palliative care needs is feasible and could reduce patients' symptom burden. DESIGN Before-after study including an internal pilot. SETTING/PARTICIPANTS Nine general practitioners working in a health region in Portugal and 53 patients with palliative care needs from their patient lists were recruited. General Practitioners received training in palliative care and used a new primary palliative care consultation model, with medical consultations every 3 weeks for 12 weeks. The primary outcome was physical symptom burden, self-reported using the Integrated Palliative care Outcome Scale (IPOS) patient version (min.0-max.1000). Secondary outcomes included emotional symptoms (min.0-max.400) and communication/practical issues (min.0-max.300). RESULTS Of the 35/53 patients completed the 12-week intervention (mean age 72.53 years, SD = 13.45; 54.7% female). All had advanced disease: one third had cancer (n = 13), one third had congestive heart failure (n = 12); others had chronic kidney disease and chronic obstructive pulmonary disease. After the 12 weeks of intervention, there was a reduction in physical symptom burden [mean difference from baseline of 71.42 (95%CI 37.01-105.85) with a medium-large effect size (0.71], and in emotional symptom burden [mean difference 42.86 (95%CI 16.14-69.58), with a medium effect size (0.55)]. No difference was found for communication/practical issues. CONCLUSIONS Our intervention can be effective in reducing patients' physical and emotional symptoms. TRIAL REGISTRATION ClinicalTrials.gov ID - NCT05244590. Registration: 14th February 2022.
Collapse
Affiliation(s)
- Carlos Seiça Cardoso
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal
| | - Filipe Prazeres
- CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal
- Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal
- USF Beira Ria, Gafanha da Nazaré, Portugal
| | - Bárbara Oliveiros
- Laboratory of Biostatistics and Medical Informatics (LBIM), Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal
- Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal
| | - Cátia Nunes
- Family Health Unit Penacova, Coimbra, Portugal
| | - Pedro Simões
- Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal
- Personalized Health Care Unit Fundão, Fundão, Portugal
| | - Carolina Aires
- Family Health Unit São Martinho de Pombal, Pombal, Portugal
| | - Patrícia Rita
- Personalized Health Care Unit Castanheira de Pera, Coimbra, Portugal
| | | | - Paulo Lopes
- Family Health Unit Rainha Santa Isabel, Torres Novas, Santarém, Portugal
| | - Sara Alcobia
- Family Health Unit As Gandras, Cantanhede, Coimbra, Portugal
| | - Sara Baptista
- Personalized Health Care Unit Figueira-da-Foz Norte, Coimbra, Portugal
| | | | - Barbara Gomes
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, London, UK
| |
Collapse
|
2
|
Anagnostou D, Katsaragakis S, Panagiotou I, Patiraki E, Tserkezoglou A. Translation and cultural adaptation of the Greek integrated palliative care outcome scale (IPOS): challenges in a six-phase process. BMC Palliat Care 2023; 22:168. [PMID: 37919682 PMCID: PMC10621102 DOI: 10.1186/s12904-023-01278-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2023] [Accepted: 10/07/2023] [Indexed: 11/04/2023] Open
Abstract
AIM To translate and culturally adapt IPOS to the Greek population. METHODS A four phases- sequential study, which included verification of conceptual equivalence, double forward- backward translations and conceptual cognitive debriefing. Focus group interviews used 'think aloud' and 'verbal probing' techniques. Interviews were audio-recorded, transcribed verbatim and thematically analyzed using predefined categories. Purposely sampled from two oncology and palliative care units in Athens. RESULTS The Integrated Palliative Care Outcome Scale was well accepted by both patients and health professionals. Overall comprehension and acceptability of the scale were good. The comprehension and judgement challenges identified in the pre-final version were successfully resolved in the cognitive interviewing phase. Five out of the seventeen translated items of the scale were modified after cognitive debriefing. Comprehension difficulties were identified with specific terms (e.g., energy/feeling depressed) and with some answer options. Severity of symptoms and not their impact was a common difficulty. A judgement challenge was reported in relation to 7-days recall and fluctuation of symptoms. Layout concerns in relation to length of questions were also stated. All questions were considered important and none as inappropriate. CONCLUSION This study demonstrated face and content validity and acceptability of the Integrated Palliative Care Outcome Scale in the Greek context. Cognitive Interviewing proved valuable in refining concepts within the specific cultural context. CLINICAL IMPLICATIONS The IPOS outcome measure tool is now being used routinely in a palliative care service in Athens and is currently used to evaluate service outcomes.
Collapse
|
3
|
Antunes B, Barclay S, Kuhn I, Eagar K, Bausewein C, Murtagh F, Etkind S, Bowers B, Dixon S, Lovick R, Harding R, Higginson I, Shokraneh F. Implementing patient-centred outcome measures in palliative care clinical practice for adults (IMPCOM): Protocol for an update systematic review of facilitators and barriers. F1000Res 2023; 12:224. [PMID: 37942019 PMCID: PMC10628357 DOI: 10.12688/f1000research.131479.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/27/2023] [Indexed: 11/10/2023] Open
Abstract
Background: Despite the development of patient-centred or patient-reported outcome measures (PCOMs or PROMs) in palliative and end-of-life care over recent years, their routine use in practice faces continuing challenges. Objective: To update a highly cited literature review, identify and synthesise new evidence on facilitators, barriers, lessons learned, PCOMs used, models of implementation, implementation outcomes, costs, and consequences of implementing PCOMs in palliative care clinical practice. Methods: We will search MEDLINE, PsycINFO, CINAHL, Embase, Emcare, SCI-Expanded, SSCI, ESCI, and BNI. The database search will be supplemented by a list of studies from the expert advisory committee, hand-searching of reference lists for included articles, and citations of the original review. We will include primary studies using a PCOM during clinical care of adult patients with advanced disease in palliative care settings and extract data on reported models of implementation, PCOMs, facilitators, barriers, lessons learned, costs, and implementation outcomes. Gough's Weight of Evidence Framework will be used to assess the robustness and relevance of the studies. We will narratively synthesise and tabulate the findings. This review will follow PRISMA, PRISMA-Abstract, PRISMA-P, and PRISMA-Search as the reporting guidelines. Source of funding: Marie Curie. The funder is not involved in designing or conducting this study. Protocol registration: CRD42023398653 (13/02/2023).
Collapse
Affiliation(s)
- Bárbara Antunes
- Palliative and End of Life Care Group in Cambridge (PELiCam), Department of Public Health and Primary Care, Primary Care Unit, The University of Cambridge, Cambridge, UK
| | - Stephen Barclay
- Palliative and End of Life Care Group in Cambridge (PELiCam), Department of Public Health and Primary Care, Primary Care Unit, The University of Cambridge, Cambridge, UK
| | - Isla Kuhn
- Medical Library, School of Clinical Medicine, The University of Cambridge, Cambridge, UK
| | - Kathy Eagar
- The Australian Health Services Research Institute, The University of Wollongong, Wollongong, Australia
| | - Claudia Bausewein
- Department of Palliative Medicine, LMU Munich, Munich University Hospital, Munich, Germany
| | - Fliss Murtagh
- Wolfson Palliative Care Research Centre, University of Hull, Hull, UK
| | - Simon Etkind
- Palliative and End of Life Care Group in Cambridge (PELiCam), Department of Public Health and Primary Care, Primary Care Unit, The University of Cambridge, Cambridge, UK
| | - Ben Bowers
- Palliative and End of Life Care Group in Cambridge (PELiCam), Department of Public Health and Primary Care, Primary Care Unit, The University of Cambridge, Cambridge, UK
| | - Sarah Dixon
- Palliative and End of Life Care Group in Cambridge (PELiCam), Department of Public Health and Primary Care, Primary Care Unit, The University of Cambridge, Cambridge, UK
| | - Roberta Lovick
- Palliative and End of Life Care Group in Cambridge (PELiCam), Department of Public Health and Primary Care, Primary Care Unit, The University of Cambridge, Cambridge, UK
| | - Richard Harding
- Department of Palliative Care and Cicely Saunders Institute, King's College London, London, UK
| | - Irene Higginson
- Department of Palliative Care and Cicely Saunders Institute, King's College London, London, UK
| | - Farhad Shokraneh
- Palliative and End of Life Care Group in Cambridge (PELiCam), Department of Public Health and Primary Care, Primary Care Unit, The University of Cambridge, Cambridge, UK
- Department of Evidence Synthesis, Systematic Review Consultants LTD, Nottingham, UK
| |
Collapse
|
4
|
Ribeiro H, Magalhães J, Cardoso T, Chaves-Castro I, Lopes-Mota C, Costa E, Rocha P, Lopes L, Bouça Â, Pereira C, Paulo Andrade J, Dourado M. Opioids and constipation therapy in the last week of life: Their impact on patients, caregivers, and the location of death. Medicine (Baltimore) 2023; 102:e32718. [PMID: 36701723 PMCID: PMC9857563 DOI: 10.1097/md.0000000000032718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The use of opioids to control pain at the end of life may cause constipation, a symptom that can negatively influence the well-being of patients and caregivers. The main aim of this study was to evaluate the impact of constipation on symptomatic control and patients' overall quality of life at this stage. A particular focus was placed on opioids. We also intended to investigate whether constipation and caregiver fatigue is related to the place of death (hospital vs home). The approach of 121 patients followed in 2021 in their last week of life by a home team specialized in palliative care was analyzed in an observational, retrospective, non-interventional study. The patients were followed up for an average of 39.7 days. A total of 82.6% wished to die at home, which occurred in 74% of the cases. The constipation prevention protocol reduced constipation by 55.1%. It seems that morphine is more related with constipation and tapentadol seems to reduce constipation induced by opioids. Patients tended to die in hospitals when their caregivers were exhausted; however, it was not possible to determine a cutoff point using the Zarit scale, which was used to assess caregiver burden. Constipation in the last week of life does not seem to influence the well-being of patients or their caregivers significantly and the individualization of intensive treatment of constipation is needed. Different opioids have different probabilities of causing adverse effects such as constipation. Future special support mechanisms can be created and activated for the most tired caregivers to avoid exhaustion and promote death at home, if that is the patient's will.
Collapse
Affiliation(s)
- Hugo Ribeiro
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
- Center for the Study and Development of Continuing and Palliative Care – Faculty of Medicine, University of Coimbra, Portugal
- Coimbra Institute for Clinical and Biomedical Research (ICBR) - Group of Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine of the University of Coimbra, Portugal
- Doctoral Program in Palliative Care at the Faculty of Medicine of the University of Porto, Portugal
- * Correspondence: Hugo Ribeiro, R. Bartolomeu Dias 316, Vila Nova DE Gaia 4430-043, Portugal (e-mail: )
| | - Júlia Magalhães
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Tatiana Cardoso
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Isabel Chaves-Castro
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Carla Lopes-Mota
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Elisabete Costa
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Patrícia Rocha
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Luísa Lopes
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Ângela Bouça
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - Cristina Pereira
- Community Support Team in Palliative Care – Group of Health Centers Gaia, Portugal
| | - José Paulo Andrade
- Department of Biomedicine – Unity of Anatomy, Faculty of Medicine of the University of Porto, Portugal
- Center for Health Technology and Services Research (CINTESIS), Porto, Portugal
| | - Marília Dourado
- Center for the Study and Development of Continuing and Palliative Care – Faculty of Medicine, University of Coimbra, Portugal
- Coimbra Institute for Clinical and Biomedical Research (ICBR) - Group of Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine of the University of Coimbra, Portugal
| |
Collapse
|
5
|
Müller E, Mayer-Steinacker R, Gencer D, Keßler J, Alt-Epping B, Schönsteiner S, Jäger H, Couné B, Elster L, Keser M, Rauser J, Marquardt S, Becker G. Feasibility, use and benefits of patient-reported outcome measures in palliative care units: a multicentre observational study. Palliat Care 2023; 22:6. [PMID: 36641450 PMCID: PMC9839955 DOI: 10.1186/s12904-022-01123-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Accepted: 12/19/2022] [Indexed: 01/15/2023] Open
Abstract
BACKGROUND Research has shown that routinely assessed, patient-reported outcome measures (PROMs) have positive effects in patients with advanced oncologic diseases. However, the transferability of these results to specialist palliative care is uncertain because patients are more impaired and staff doubt the feasibility and benefits. The aim of this study is to evaluate the feasibility of patient self-assessment of PROMs, their use by staff and the benefits in palliative care wards. METHOD A multicentre observational study was conducted in the context of the implementation of the Integrated Patient Outcome Scale (IPOS) in three specialist palliative care wards at university hospitals in Germany. All admitted patients who screened positive regarding their ability to complete questionnaires were asked to participate and complete the IPOS on paper weekly, with assistance if necessary. Feasibility of questionnaire completion (e.g. proportion of patients able to complete them), use (e.g. involvement of different professional groups) and benefit (e.g. unexpected information in IPOS as rated by treating physicians) were assessed. Staff members' opinion was obtained in a written, anonymous evaluation survey, patients' opinion in a short written evaluation. RESULTS A total of 557 patients were screened for eligibility, 235 were assessed as able to complete the IPOS (42.2%) and 137 participated in the study (24.6%). A majority needed support in completing the IPOS; 40 staff members and 73 patients completed the evaluation. Unexpected information was marked by physicians in 95 of the 137 patient questionnaires (69.3%). The staff differed in their opinions on the question of whether this also improved treatment. A majority of 32 staff members (80.0%) were in favour of continuing the use of IPOS (4 against continuation, 4 no answer); 43 (58.9%) patients rated their overall experience of IPOS use as 'positive', 29 (39.7%) as 'neutral' and 1 (1.4%) as 'negative'. CONCLUSIONS While most staff wished to continue using IPOS, it was a challenge to integrate the effort to support the completion of IPOS into daily practice. Digital implementation was not successful, despite various attempts. To explore the effects on care and patient outcomes, multicentre cluster-randomised trials could be employed. TRIAL REGISTRATION German Clinical Trials Register DRKS-ID: DRKS00016681 (24/04/2019).
Collapse
Affiliation(s)
- Evelyn Müller
- grid.5963.9Department of Palliative Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Regine Mayer-Steinacker
- grid.410712.10000 0004 0473 882XDepartment of Hematology and Oncology, Comprehensive Cancer Center, University Medical Center Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany ,Competence Centre Palliative Care of Baden-Wuerttemberg, Baden-Wuerttemberg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Deniz Gencer
- grid.411778.c0000 0001 2162 1728Department of Hematology and Oncology, Mannheim Cancer Center, Mannheim University Hospital, Mannheim Faculty of Medicine, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany ,Competence Centre Palliative Care of Baden-Wuerttemberg, Baden-Wuerttemberg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Jens Keßler
- grid.5253.10000 0001 0328 4908Department of Anaesthesiology, Devision of Pain Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 131, 69120 Heidelberg, Germany ,Competence Centre Palliative Care of Baden-Wuerttemberg, Baden-Wuerttemberg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Bernd Alt-Epping
- Competence Centre Palliative Care of Baden-Wuerttemberg, Baden-Wuerttemberg, Robert-Koch Str. 3, 79106 Freiburg, Germany ,grid.5253.10000 0001 0328 4908Department of Palliative Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 305, Heidelberg, 69120 Germany
| | - Stefan Schönsteiner
- grid.410712.10000 0004 0473 882XDepartment of Hematology and Oncology, Comprehensive Cancer Center, University Medical Center Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany ,Competence Centre Palliative Care of Baden-Wuerttemberg, Baden-Wuerttemberg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Helga Jäger
- grid.5963.9Department of Palliative Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Bettina Couné
- grid.5963.9Department of Palliative Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Luise Elster
- grid.5963.9Department of Palliative Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| | - Muhammet Keser
- grid.411778.c0000 0001 2162 1728Department of Hematology and Oncology, Mannheim Cancer Center, Mannheim University Hospital, Mannheim Faculty of Medicine, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
| | - Julia Rauser
- grid.410712.10000 0004 0473 882XDepartment of Hematology and Oncology, Comprehensive Cancer Center, University Medical Center Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany
| | - Susanne Marquardt
- grid.5253.10000 0001 0328 4908Department of Anaesthesiology, Devision of Pain Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 131, 69120 Heidelberg, Germany
| | - Gerhild Becker
- grid.5963.9Department of Palliative Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch Str. 3, 79106 Freiburg, Germany ,Competence Centre Palliative Care of Baden-Wuerttemberg, Baden-Wuerttemberg, Robert-Koch Str. 3, 79106 Freiburg, Germany
| |
Collapse
|
6
|
Fernandes CS, Vale MB, Magalhães B, Castro JP, Azevedo MD, Lourenço M. Developing a Card Game for Assessment and Intervention in the Person and the Family in Palliative Care: " Pallium Game". INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:1449. [PMID: 36674205 PMCID: PMC9859236 DOI: 10.3390/ijerph20021449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Revised: 01/10/2023] [Accepted: 01/11/2023] [Indexed: 06/17/2023]
Abstract
Communication between the multidisciplinary team, the person, and the family in palliative and end-of-life situations implies, in most situations, a high negative emotional burden. Therefore, innovative strategies are needed to reduce it. The goal of this study is to describe the various stages of development and validation of a collaborative card game for people in palliative care and their families. Phase one is an exploratory study, Phase two is a Delphi study, and Phase three is a multiple case study. Participants for phases 2 and 3 were recruited using a convenience sampling method. The results demonstrate in an organized and structured way the different phases required to build a collaborative card game. The use of the game was found to be useful and effective. Four categories emerged from the content analysis of the open-ended responses: usability, evaluation tool, communication and therapeutic relationship, and meaning when using the game. A collaborative game in palliative care helps to create a space for individuals and families to express feelings and experiences, meeting the myriad of physical, psychosocial, and spiritual needs. The "Pallium game" is a useful and impactful approach to discussing sensitive topics in palliative care.
Collapse
Affiliation(s)
- Carla Sílvia Fernandes
- Nursing School of Porto, Center for Health Technology and Services Research (CINTESIS), 4200-450 Porto, Portugal
| | - M. Belém Vale
- Nursing in Hospital da Luz-Póvoa de Varzim, 4490-592 Póvoa de Varzim, Portugal
| | - Bruno Magalhães
- Department of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO), 4200-072 Porto, Portugal
- Oncology Nursing Research Unit IPO Porto Research Center (CI-IPOP), Portuguese (IPO Porto) Comprehensive Cancer Centre (Porto. CCC) & RISE@CI-IPOP (Health Research Network), 4200-072 Porto, Portugal
- School of Health, University of Trás-os-Montes e Alto Douro (UTAD), 5000-801 Vila Real, Portugal
| | - João P. Castro
- Wecare Saúde—Continuous Integrated and Palliative Care Unit, 4490-492 Póvoa de Varzim, Portugal
| | - Marta D. Azevedo
- Wecare Saúde—Continuous Integrated and Palliative Care Unit, 4490-492 Póvoa de Varzim, Portugal
| | - Marisa Lourenço
- Nursing School of Porto, Center for Health Technology and Services Research (CINTESIS), 4200-450 Porto, Portugal
| |
Collapse
|
7
|
Neo SHS, Tan JYT, Sim DKL, Ng ESL, Loh JKX, Yang GM, Murtagh FE, Cheung YB. Validity and Reliability of the Integrated Palliative Care Outcome Scale in Asian Heart Failure Patients. Palliat Med Rep 2022; 3:287-295. [DOI: 10.1089/pmr.2022.0029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/26/2022] [Indexed: 11/23/2022] Open
Affiliation(s)
- Shirlyn Hui-Shan Neo
- Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore
- Lien Centre for Palliative Care, Duke-NUS Medical School, Singapore, Singapore
| | - Jasmine Yun-Ting Tan
- Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore
| | | | - Elaine Swee-Ling Ng
- Nursing Specialty Care Unit, National Heart Centre Singapore, Singapore, Singapore
| | | | - Grace Meijuan Yang
- Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore
- Lien Centre for Palliative Care, Duke-NUS Medical School, Singapore, Singapore
| | - Fliss E.M. Murtagh
- Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom
| | - Yin Bun Cheung
- Program in Health Services & Systems Research and Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore
- Centre for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland
| |
Collapse
|
8
|
Higginson IJ, Hocaoglu MB, Fraser LK, Maddocks M, Sleeman KE, Oluyase AO, Chambers RL, Preston N, Dunleavy L, Bradshaw A, Bajwah S, Murtagh FEM, Walshe C. Symptom Control and Survival for People Severely ill With COVID: A Multicentre Cohort Study (CovPall-Symptom). J Pain Symptom Manage 2022; 64:377-390. [PMID: 35752399 DOI: 10.1016/j.jpainsymman.2022.06.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2022] [Revised: 06/01/2022] [Accepted: 06/15/2022] [Indexed: 11/17/2022]
Abstract
CONTEXT Evidence of symptom control outcomes in severe COVID is scant. OBJECTIVES To determine changes in symptoms among people severely ill or dying with COVID supported by palliative care, and associations with treatments and survival. METHODS Multicentre cohort study of people with COVID across England and Wales supported by palliative care services, during the pandemic in 2020 and 2021. We analysed clinical, demographic and survival data, symptom severity at baseline (referral to palliative care, first COVID assessment) and at three follow-up assessments using the Integrated Palliative care Outcome Scale - COVID version. RESULTS We included 572 patients from 25 services, mostly hospital support teams; 496 (87%) were newly referred to palliative care with COVID, 75 (13%) were already supported by palliative care when they contracted COVID. At baseline, patients had a mean of 2.4 co-morbidities, mean age 77 years, a mean of five symptoms, and were often bedfast or semiconscious. The most prevalent symptoms were: breathlessness, weakness/lack of energy, drowsiness, anxiety, agitation, confusion/delirium, and pain. Median time in palliative care was 46 hours; 77% of patients died. During palliative care, breathlessness, agitation, anxiety, delirium, cough, fever, pain, sore/dry mouth and nausea improved; drowsiness became worse. Common treatments were low dose morphine and midazolam. Having moderate to severe breathlessness, agitation and multimorbidity were associated with shorter survival. CONCLUSION Symptoms of COVID quickly improved during palliative care. Breathlessness, agitation and multimorbidity could be used as triggers for timelier referral, and symptom guidance for wider specialities should build on treatments identified in this study.
Collapse
Affiliation(s)
- Irene J Higginson
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK; King's College Hospital NHS Foundation Trust (I.J.H., K.F.S.), Denmark Hill, UK.
| | - Mevhibe B Hocaoglu
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK
| | - Lorna K Fraser
- Health Sciences (L.K.F.), University of York, York, North Yorkshire, UK
| | - Matthew Maddocks
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK
| | - Katherine E Sleeman
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK; King's College Hospital NHS Foundation Trust (I.J.H., K.F.S.), Denmark Hill, UK
| | - Adejoke O Oluyase
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK
| | - Rachel L Chambers
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK
| | - Nancy Preston
- International Observatory on End of Life Care (N.P., L.D., C.W.), Division of Health Research, Lancaster University, Lancaster, UK
| | - Lesley Dunleavy
- International Observatory on End of Life Care (N.P., L.D., C.W.), Division of Health Research, Lancaster University, Lancaster, UK
| | - Andy Bradshaw
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK; Wolfson Palliative Care Research Centre (A.B., F.E.M.M.), Hull York Medical School, University of Hull, Hull, UK
| | - Sabrina Bajwah
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK
| | - Fliss E M Murtagh
- Wolfson Palliative Care Research Centre (A.B., F.E.M.M.), Hull York Medical School, University of Hull, Hull, UK
| | - Catherine Walshe
- International Observatory on End of Life Care (N.P., L.D., C.W.), Division of Health Research, Lancaster University, Lancaster, UK
| | -
- Cicely Saunders Institute of Palliative Care (I.J.H., M.H., M.M., K.F.S., A.O.O., R.L.C., S.B.), Policy and Rehabilitation, King's College London, London, UK; Wolfson Palliative Care Research Centre (A.B., F.E.M.M.), Hull York Medical School, University of Hull, Hull, UK; International Observatory on End of Life Care (N.P., L.D., C.W.), Division of Health Research, Lancaster University, Lancaster, UK
| |
Collapse
|
9
|
Martinsson L, Sahlén KG. Translation and cultural adaptation of the Integrated Palliative care Outcome Scale for Dementia (IPOS-Dem) to Swedish. BMC Nurs 2022; 21:78. [PMID: 35365128 PMCID: PMC8975724 DOI: 10.1186/s12912-022-00859-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Accepted: 03/28/2022] [Indexed: 11/10/2022] Open
Abstract
INTRODUCTION Systematic assessment tools are helpful for improving and maintaining quality of care. The Integrated Palliative care Outcome Scale (IPOS) was developed for systematic assessment of persons receiving palliative care in a patient-centred way. A version of this tool, the Integrated Palliative care Outcome Scale for Dementia (IPOS-Dem), has been developed for patients with dementia. The aim of this study was to develop a version of the IPOS-Dem translated into Swedish and culturally adapted to a Swedish care setting. METHODS Forward and backward translations from English into Swedish were performed to develop a first Swedish version. This version was modified for clarity and cultural adaptation based on 13 interviews with nurses and assistant nurses working in geriatrics and dementia care homes. RESULTS The interview process revealed several issues with the first version that emerged from the translation process. This was changed and further tested to work well, resulting in the final version of the Swedish IPOS-Dem. The tool was perceived as clinically useful but somewhat overlapping with already implemented tools for assessing behavioural and psychological symptoms in dementia. CONCLUSION The Swedish version of the IPOS-Dem can now be used as a tool for assessing palliative care related problems and concerns for persons with advanced dementia. Future studies can focus on implementation as well as examining validity and reliability of this tool in a Swedish context.
Collapse
Affiliation(s)
- Lisa Martinsson
- Department of Radiation Sciences, Umeå University, 901 87, Umeå, Sweden.
| | - Klas-Göran Sahlén
- Epidemiology and Global Health, Umeå University, 901 87, Umeå, Sweden
| |
Collapse
|
10
|
Hamatani Y, Iguchi M, Ikeyama Y, Kunugida A, Ogawa M, Yasuda N, Fujimoto K, Ichihara H, Sakai M, Kinoshita T, Nakashima Y, Akao M. Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients. ESC Heart Fail 2022; 9:1963-1975. [PMID: 35307988 PMCID: PMC9065822 DOI: 10.1002/ehf2.13907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Revised: 03/02/2022] [Accepted: 03/07/2022] [Indexed: 11/06/2022] Open
Abstract
Aims Patients with heart failure (HF) may have variable unrecognized symptom burdens. We sought to investigate the details, determinants, and prognostic significance of symptom burden in hospitalized patients with HF. Methods and results We prospectively evaluated consecutive hospitalized patients with HF as primary diagnosis at our institution using the Integrated Palliative care Outcome Scale (IPOS) both on admission and at discharge. The IPOS, which is a well‐validated multi‐dimensional symptom assessment scale among advanced illness, consists of 17 questions for enquiring about physical symptoms (10 items), emotional symptoms (4 items) and communication and practical issues (3 items) using a 5‐point Likert scale (0 [best]–4 [worst] points). Clinically relevant symptoms were defined as ≥2 points for each IPOS item. Worsening symptom burden was defined as the total IPOS score at discharge being poorer than that on admission. Of 294 patients (mean age: 77.5 ± 12.0 years, male: 168 patients, New York Heart Association class IV: 96 patients, mean left ventricular ejection fraction [LVEF]: 44%, and median N‐terminal pro B‐type natriuretic peptide [NT‐proBNP] level: 4418 ng/L), the median (IQR) total IPOS score on admission was 19 (12, 27) and they were widely distributed (minimum: 0 – maximum: 52). The total IPOS score on admission was not correlated with the HF severity, including LVEF (Spearman's ρ = −0.05, P = 0.43), NT‐proBNP levels (Spearman's ρ = 0.08, P = 0.20) or in‐hospital mortality prediction model (GWTG‐HF risk score) (Spearman's ρ = 0.01, P = 0.90). Total IPOS scores significantly decreased during hospitalization as a whole (median [IQR]: 13 [6, 21] at discharge; P < 0.001 vs. those on admission). All of the four emotional symptoms (patient anxiety, depression, family anxiety and feeling at peace) remained in the top 5 of clinically relevant symptoms at discharge, whereas none of 10 physical symptoms were nominated. Worsening symptom burden was noted in 28% of the patients during hospitalization, and was independently associated with higher all‐cause mortality after discharge (hazard ratio: 2.28, 95% confidence interval: 1.02–5.09; P = 0.044) even after adjustment by age and HF mortality prediction model (MAGGIC risk score). Conclusions We revealed that hospitalized patients with HF had multi‐dimensional symptom burdens which varied among individuals and were not correlated with the disease severity. Emotional symptoms, such as anxiety and depression, were the main clinically relevant symptoms at discharge. A worsening IPOS score was noted in a quarter of patients with HF and was associated with a poor prognosis, suggesting the importance of holistic symptom assessment during the course of hospitalization for HF.
Collapse
Affiliation(s)
- Yasuhiro Hamatani
- Department of Cardiology National Hospital Organization Kyoto Medical Center 1‐1, Mukaihata‐cho, Fukakusa, Fushimi‐ku Kyoto 612‐8555 Japan
| | - Moritake Iguchi
- Department of Cardiology National Hospital Organization Kyoto Medical Center 1‐1, Mukaihata‐cho, Fukakusa, Fushimi‐ku Kyoto 612‐8555 Japan
| | - Yurika Ikeyama
- Department of Nursing National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Atsuko Kunugida
- Department of Nursing National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Megumi Ogawa
- Department of Nursing National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Natsushige Yasuda
- Department of Rehabilitation National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Kana Fujimoto
- Department of Pharmacy National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Hidenori Ichihara
- Department of Pharmacy National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Misaki Sakai
- Department of Nursing National Hospital Organization Kyoto Medical Center Kyoto Japan
- Department of Palliative Care Medicine National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Tae Kinoshita
- Department of Palliative Care Medicine National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Yasuyo Nakashima
- Department of Rehabilitation National Hospital Organization Kyoto Medical Center Kyoto Japan
| | - Masaharu Akao
- Department of Cardiology National Hospital Organization Kyoto Medical Center 1‐1, Mukaihata‐cho, Fukakusa, Fushimi‐ku Kyoto 612‐8555 Japan
| |
Collapse
|
11
|
Mendonça L, Antunes B, Rigor J, Martins-Mendes D, Monteiro-Soares M. Characterizing palliative care needs in people with or at risk of developing diabetic foot ulcers. Ther Adv Endocrinol Metab 2022; 13:20420188221136770. [PMID: 36406834 PMCID: PMC9666889 DOI: 10.1177/20420188221136770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Accepted: 10/15/2022] [Indexed: 11/16/2022] Open
Abstract
AIMS Diabetic foot ulcers (DFUs) have a significant impact on a patient's quality of life and life expectancy, with mortality rates comparable with malignant diseases. However, there is a lack of data regarding palliative care needs in this population. We aimed to characterize palliative care needs in people under diabetic foot surveillance using the Integrated Palliative care Outcome Scale (IPOS) and EuroQol-5D three-level version (EQ-5D-3L) and to assess differences between those with and without a DFU. METHODS We conducted a cross-sectional study with consecutive sampling inclusion of patients followed in a tertiary hospital's Diabetic Foot Clinic between February and October 2019 with (n = 20) and without (n = 42) active DFU. RESULTS The most frequent symptoms encountered were pain, weakness or lack of energy, sore or dry mouth and drowsiness. Patients with an active DFU were significantly more likely to report feeling anxious or worried in comparison with those without (95% versus 55%, p = 0.002). Only 10% of the participants with an active DFU said that they were always able to share how they felt with family and friends as much as they wanted in comparison with 45% of those without (p = 0.006). CONCLUSION Our study identified palliative care needs in patients under diabetic foot surveillance with and without DFU, including a significant presence of physical symptoms. Patients in both groups showed signs of emotional/psychological distress, with a higher manifestation in patients with DFU. To the best of our knowledge, this is the first study addressing and characterizing palliative care needs in this population.
Collapse
Affiliation(s)
- Liliane Mendonça
- MEDCIDS – Departamento de Medicina da
Comunidade Informação e Decisão em Saúde, Faculty of Medicine, University of
Porto, Portugal
| | - Bárbara Antunes
- Primary Care Unit, Department of Public Health
and Primary Care, University of Cambridge, Cambridge, UK
| | - Joana Rigor
- Centro Hospitalar de Vila Nova de Gaia/Espinho,
EPE, Vila Nova de Gaia, Portugal
| | | | | |
Collapse
|
12
|
Kebebew T, Mavhandu-Mudzusi AH, Mosalo A. A cross-sectional assessment of symptom burden among patients with advanced cervical cancer. BMC Palliat Care 2021; 20:190. [PMID: 34920716 PMCID: PMC8684193 DOI: 10.1186/s12904-021-00883-3] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Accepted: 11/15/2021] [Indexed: 11/28/2022] Open
Abstract
Background The increasing burden of chronic non-communicable diseases in developing countries is driving attention to palliative care services. Identification of disease-specific symptoms of concern and their prevalence will guide designing, monitoring, and evaluating palliative care programmes. This study assessed the burden of symptoms and problems among patients with advanced cervical cancer. Methods This research followed a cross-sectional study design to quantitatively review the symptom burden among patients diagnosed with advanced cervical cancer attending treatment at Tikur Anbessa Specialised Hospital, Addis Ababa, Ethiopia from January to July 2019. Symptoms were assessed using a patient-reported, seven-day recall Integrated Palliative Care Outcome Scale (IPOS) version III. Frequency, median and mean scores with a standard deviation were used in the descriptive analysis whereas t-test and one-way analysis of variance were used for comparisons. Results There were 385 patients with advanced cervical cancer, stage IIB-IVB, successfully interviewed. The median age was 50 years, the majority were illiterate (63.1%) and in marital union (62.3%). Over 50% of the patients experienced pain, weakness, poor appetite, constipation, limited mobility, and dry mouth. The burdens of emotional symptoms such as patient anxiety, family anxiety, and patient depression were also prevalent at 79.7%, 82.3%, and 47.0%, respectively. Patients who are illiterate, at a higher stage of the disease, not currently in marriage, and who received palliative radiotherapy bear a higher symptom burden. Conclusion Patients with advanced cervical cancer bear a high symptom burden. Early initiation of palliative care is recommended to alleviate the concerning symptoms, and to improve patients’ quality of life.
Collapse
Affiliation(s)
- Tolcha Kebebew
- Student at University of South Africa, Ethiopia Learning Centre, Addis Ababa, Ethiopia.
| | | | - Annah Mosalo
- Department of Health Studies, University of South Africa, Pretoria, South Africa
| |
Collapse
|
13
|
Psychometric validation and cross-cultural adaptation of the Integrated Palliative care Outcome Scale in Polish (IPOS-Pol). Palliat Support Care 2021; 20:687-693. [PMID: 34579798 DOI: 10.1017/s1478951521001176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
OBJECTIVE The study aimed to assess the reliability and validity of the IPOS-Pol for patient self-reporting. METHOD Patients (>18 years of age) with advanced cancer admitted to three palliative care centers (inpatient units and home-based) were recruited to a multicenter, cross-sectional, observational, prospective study. Participants provided responses to the IPOS-Pol Patient version and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 15 - Palliative Care (EORTC QLQ-C15-PAL) Polish version at baseline (T1) and four to seven days later (T2). We assessed test-retest reliability, internal consistency, and construct validity of the tool. RESULTS One hundred and eighty patients were included. Test-retest reliability demonstrated no statistically significant differences in the average outcomes of the IPOS-Pol between T1 and T2 (27.2 ± 9.2 vs. 26.5 ± 8.7; p > 0.05). The intra-class correlation coefficient between T1 and T2 was r = 0.83 (p < 0.0001), the intra-class correlation coefficient for test-retest reliability of the IPOS-Pol items ranged from 0.63 to 0.84 (p < 0.0001), and the Cronbach's α coefficient for internal consistency was 0.773. The correlation coefficient between the IPOS-Pol and EORTC QLQ-C15-PAL total score was 0.79 (p < 0.001). SIGNIFICANCE OF RESULTS The patient version of the Polish adaptation of IPOS is a valid and reliable outcome measure for assessing symptoms and concerns of individuals receiving palliative care, as well as the quality of care provided.
Collapse
|